 |
More details from the US National MS Society on the DNA vaccine study.
An early-phase study of BHT-3009, both alone and in combination with Lipitor® found the drug to be safe and to induce a beneficial immune response in relapsing-remitting or secondary-progressive MS.
To read more, please click on the link below.
Source: US National MS Society
Weblink: click here
|
